Home

VAUGHN M KAILIAN

CIK 1180429 · President and CEO · last filed 2015-07-21

VAUGHN M KAILIAN is a President and CEO who has filed 12 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for CHMA, was dated Jul 21, 2015. Across all open-market trades the lifetime net is +$15.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $298.9M across reported positions. 35 SEC filings were submitted jointly with ANSBERT GADICKE.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$298.88M

Companies

5

Total Filings

12

Lifetime Open-Market Net

$15.36M

Filer Profile

Reported Address
P.O. BOX 70
BODEGA, CA 94922
Formerly Known As
KAILIAN VAUGH M (2002–2002)
Related Filers
ANSBERT GADICKE — 35 joint filings, latest 2016-03-09
LUKE EVNIN — 33 joint filings, latest 2015-10-20
James Paul Scopa — 30 joint filings, latest 2016-09-29
John Vander Vort — 28 joint filings, latest 2013-08-01
Steven St Peter — 24 joint filings, latest 2012-02-03
Todd Foley — 22 joint filings, latest 2016-09-29
Ashley L. Dombkowski — 20 joint filings, latest 2011-05-19
William Greene — 20 joint filings, latest 2011-05-19
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CHIASMA, INC (CHMA) Delisted 10%+ Owner 5,681,544 $3.76 $21.36M $0 1 2015-07-21
Histogen Inc. (CNAT) Delisted 10%+ Owner 101,010 — — $9.09M 1 2013-08-01
CEPHALON INC (CEPH) Delisted Director — — — $0 6 2011-10-17
PCRX 10%+ Owner 2,561,084 $25.19 $64.51M $7.50M 1 2011-02-10
MEMY President and CEO 14,228,773 $16.47 $234.36M -$1.23M 3 2008-02-12

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2015-07-21 CHIASMA, INC (CHMA) Delisted Conv (C) +51,133,896 $0 EDGAR
2013-08-01 Histogen Inc. (CNAT) Delisted Mixed +5,960,400 $10.01M EDGAR
2011-10-17 CEPHALON INC (CEPH) Delisted Disp (D) — $0 EDGAR
2011-05-12 CEPHALON INC (CEPH) Delisted Grant (A) — $0 EDGAR
2011-02-10 PCRX Mixed +5,471,922 $7.50M EDGAR
2010-05-21 CEPHALON INC (CEPH) Delisted Grant (A) — $0 EDGAR
2009-05-14 CEPHALON INC (CEPH) Delisted Grant (A) — $0 EDGAR
2008-05-27 CEPHALON INC (CEPH) Delisted Grant (A) — $0 EDGAR
2008-02-12 MEMY Grant (A) — $0 EDGAR
2007-09-14 MEMY Sell (S) −577,440 -$1.23M EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.